Abstract Number: 923 • 2012 ACR/ARHP Annual Meeting
Low Bone Mineral Density and Higher Parathyroid Hormone Levels As Independent Factors to All-Cause Mortality in Community-Dwelling Older Adults: the São Paulo Ageing & Health Study (SPAH)
Background/Purpose: Previous studies have shown a relationship between osteoporosis and increased risk of death. Moreover, secondary hyperparathyroidism has been linked to mortality amongst frail older…Abstract Number: 924 • 2012 ACR/ARHP Annual Meeting
Methods to Link a U.S. Arthritis Cohort with Medicare Administrative Claims Data
Background/Purpose: Linkages between clinical and administrative data may provide a valuable resource for pharmacoepidemiologic and health services research. Objective To describe methods and validity of…Abstract Number: 925 • 2012 ACR/ARHP Annual Meeting
Use of Rheumatology Services for Arthritis: The Role of SES and Geographic Availability of Rheumatologists and Primary Care Physicians
Background/Purpose: Access to rheumatology is critical for timely treatment of new onset inflammatory arthritis (IA). Barriers to timely care include patient characteristics, the need for…Abstract Number: 926 • 2012 ACR/ARHP Annual Meeting
Accuracy of Canadian Health Administrative Databases in Identifying Patients with Rheumatoid Arthritis Using a Random Sample of 7500 Patients Seen in Primary Care
Background/Purpose: The use of population-based health administrative databases in rheumatology research is well established, but there are ongoing concerns about validity. To date, previous validation…Abstract Number: 927 • 2012 ACR/ARHP Annual Meeting
Shared Decision Making in Secondary Care: Rheumatologic Patient’s Perspective
Background/Purpose: This cross-sectional study aimed to analyze the willingness for shared decision making (SDM) of rheumatologic patients. Methods: All rheumatic disease patients assisted at a…Abstract Number: 928 • 2012 ACR/ARHP Annual Meeting
Is There an Optimal Treatment Strategy for Disease-Modifying-Antirheumatic-Drug Naïve Patients with Rheumatoid Arthritis?
Background/Purpose: There is a lack of head-to-head clinical trial data to determine the most effective treatment for rheumatoid arthritis (RA). However, these trials have had…Abstract Number: 929 • 2012 ACR/ARHP Annual Meeting
Epidemiology of the US National Burden of Pediatric Lupus Hospitalization From 2000-2009
Background/Purpose: Studies indicate that of 11% of adult hospitalizations are related to systemic lupus erythematosus (SLE), with an average charge of $10,000 US per hospitalization…Abstract Number: 930 • 2012 ACR/ARHP Annual Meeting
Disease Burden and Cost of Illness in SLE During 8 Years Follow up
Background/Purpose: To study the annual direct and indirect costs in SLE in a cohort, from a defined area in southern Sweden, and to find potential…Abstract Number: 931 • 2012 ACR/ARHP Annual Meeting
Health Care Utilization Among Medicaid Enrollees with Systemic Lupus Erythematosus Preceding the Development of End-Stage Renal Disease: Sociodemographic Variation
Background/Purpose: Extreme sociodemographic disparities exist among systemic lupus erythematosus (SLE) patients in the development of end-stage renal disease (ESRD) from lupus nephritis. Better resource allocation…Abstract Number: 932 • 2012 ACR/ARHP Annual Meeting
Medical Costs and Health Care Resource Use in Patients with Systemic Lupus Erythematosus in an Insured Population
Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that may affect multiple organ systems. The clinical manifestations of SLE are heterogeneous, and subjects…Abstract Number: 933 • 2012 ACR/ARHP Annual Meeting
Economic Burden of Systemic Lupus Erythematosus by Flare Severity in a Commercially Insured Population in the United States
Background/Purpose: Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease with an unpredictable disease course with sporadic periods of illness (flares). Little is known about…Abstract Number: 894 • 2012 ACR/ARHP Annual Meeting
Genetic Variants in the IL-4 and IL-4 Receptor Genes in Association with the Severity of Joint Damage in Rheumatoid Arthritis: A Study in Seven Cohorts
Background/Purpose: The severity of RA is reflected by the severity of radiological joint destruction. It is highly variable between patients and up to 58% of…Abstract Number: 895 • 2012 ACR/ARHP Annual Meeting
Transcriptomics of Synovial Tissue of Early Human (CHECK) and Experimental OA Identify Pathways Associated with Cartilage Damage
Background/Purpose: Many osteoarthritis (OA) patients show synovial inflammation, even relatively early during the disease. Mechanisms through which synovial activation contributes to the joint pathology that…Abstract Number: 896 • 2012 ACR/ARHP Annual Meeting
Tyro3, Axl, MerTK-Receptor Activation by Gas6 or Pros1 Gene Delivery, ameliorates Collagen-induced arthritis
Background/Purpose: Insufficient controlled activation of innate immunity by cytokines and pattern recognition receptors could develop into auto-immune diseases. Stimulation of dendritic cells via the Axl receptor…Abstract Number: 897 • 2012 ACR/ARHP Annual Meeting
IL-33 Promotes Mast Cell Survivial Via Inhibition of Apoptosis Associated with Enhanced Expression of Bcl-XL
Background/Purpose: Mast cells (MCs) are potent innate immune cells that frequently accumulate in chronically inflamed tissues, including the arthritic synovium. The factors that regulate MC…